85 results
10-Q
2018 Q1
ZOM
Zomedica Corp
15 May 18
Quarterly report
12:00am
:
Research and development
General and administrative
Professional fees
Amortization
Depreciation
Loss from operations
Gain on settlement of liabilities … consolidated financial statements.
Research and development costs related to continued research and development programs are expensed as incurred
424B3
ZOM
Zomedica Corp
15 May 18
Prospectus supplement
4:35pm
(Stated in United States dollars)
Note
March 31,
Expenses:
Research and development
General and administrative
Professional fees
Amortization … and companies presented in the condensed unaudited interim consolidated financial statements.
Research and development costs related to continued research
424B3
s1j orc7bgssvi
13 Nov 18
Prospectus supplement
5:07pm
424B3
ycc4gjoiv9099bsi
9 Aug 18
Prospectus supplement
4:16pm
8-K
EX-99.1
s5r6clxr7d4vy18hlb0g
1 Mar 22
Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results
4:52pm
8-K
EX-99.1
r14fy6aul4 7uxvzuqq
8 Aug 19
Zomedica Announces Second Quarter 2019 Financial Results
4:16pm
8-K
EX-99.1
4aomvb 91ywffpq
12 Nov 19
Zomedica Announces Third Quarter 2019 Financial Results
4:58pm
8-K
EX-99.1
it17n
11 May 23
Results of Operations and Financial Condition
4:27pm